The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Matching-adjusted indirect comparison (MAIC) of olutasidenib (OLU) and ivosidenib (IVO) in isocitrate dehydrogenase 1 (IDH1)-mutated relapsed/refractory (R/R) acute myeloid leukemia (AML).
 
Justin Watts
Consulting or Advisory Role - Aptose Biosciences; Bristol-Myers Squibb; Daiichi Sankyo; Incyte; Opna Bio; Rigel; SERVIER
Research Funding - Immune System Key; Rigel
 
Brian Jonas
Consulting or Advisory Role - Abbvie; BMS; Gilead Sciences; Kura Oncology; Rigel; Schrodinger; Syndax; Treadwell Therapeutics
Research Funding - Abbvie (Inst); Amgen (Inst); Aptose Biosciences (Inst); AROG (Inst); Biomea Fusion (Inst); BMS (Inst); Celgene (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immune-Onc Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Kymera (Inst); Loxo (Inst); Pfizer (Inst); Pharmacyclics (Inst); Treadwell Therapeutics (Inst)
Travel, Accommodations, Expenses - Rigel
Other Relationship - Gilead Sciences
 
Eunice Wang
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Daiichi Sankyo/UCB Japan; GlaxoSmithKline; Immunogen; Johnson & Johnson/Janssen; Kite/Gilead; Kura Oncology; Novartis; Qiagen; Rigel; Ryvu Therapeutics; Schrodinger; SERVIER; Stemline Therapeutics; Sumitomo Pharma Oncology; Syndax; Takeda
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo/UCB Japan; DAVA Pharmaceuticals; Pfizer
Other Relationship - Abbvie/Genentech; Gilead Sciences; Gilead Sciences; UpToDate
 
Florence Wilson
Employment - Precision AQ
Consulting or Advisory Role - Rigel Pharmaceuticals Inc. (Inst)
 
Julie Park
Employment - Precision AQ
Stock and Other Ownership Interests - Moderna Therapeutics
Consulting or Advisory Role - Rigel Pharmaceuticals Inc. (Inst)
 
Shannon Cope
Employment - Precision AQ
Stock and Other Ownership Interests - Precision AQ
Consulting or Advisory Role - Rigel Pharmaceuticals Inc. (Inst)
Research Funding - Precision AQ
 
Aaron Sheppard
Employment - Rigel
Stock and Other Ownership Interests - Rigel
Travel, Accommodations, Expenses - Rigel
 
Stéphane De Botton
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bayer; Celgene; Daiichi Sankyo; Forma Therapeutics; Janssen-Cilag; Pfizer; Seagen; Syros Pharmaceuticals
Speakers' Bureau - Abbvie; Astellas Pharma; Celgene; Daiichi Sankyo; Janssen-Cilag; Jazz Pharmaceuticals
Research Funding - Agios (Inst); Forma Therapeutics (Inst)
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; FORMA Therapeutics; Novartis; Pfizer; Seagen; Syros Pharmaceuticals
 
Jorge Cortes
Consulting or Advisory Role - Bio-Path Holdings, Inc; Enliven Therapeutics; Gilead Sciences; Novartis; Pfizer; Rigel; Sun Pharma; Syndax; Takeda; Terns Pharmaceuticals
Research Funding - Abbvie/Genentech (Inst); Actuate Therapeutics (Inst); Bio-Path Holdings, Inc (Inst); Cyto Agents (Inst); Jazz Pharmaceuticals (Inst); Kuro Oncology (Inst); Novartis (Inst); Pfizer (Inst); Sellas Life Sciences (Inst); Sun Pharma (Inst)